Average Co-Inventor Count = 2.60
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (46 from 3,681 patents)
2. E. R. Squibb Sons, Inc. (36 from 1,624 patents)
3. Squibb & Sons, Inc. (0 patent)
4. Das, Jagabandhu (0 patent)
5. Haslanger, Martin F. (0 patent)
6. Floyd, David M. (0 patent)
7. Krapcho, John (0 patent)
8. R.r. Squibb & Sons, Inc. (0 patent)
82 patents:
1. 9382219 - Cyclic protein tyrosine kinase inhibitors
2. 9221826 - Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
3. 9216972 - Tricyclic heterocyclic compounds
4. 9187437 - Substituted oxadiazole compounds
5. 8993567 - Cyclic protein tyrosine kinase inhibitors
6. 8987268 - Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
7. 8822510 - Substituted 3-phenyl-1,2,4-Oxadiazole compounds
8. 8716323 - Cyclic protein tyrosine kinase inhibitors
9. 8404689 - Heterocyclic amide compounds useful as kinase inhibitors
10. 8268855 - [object Object]
11. 7935696 - Heterocyclic amide compounds useful as kinase inhibitors
12. 7737279 - [object Object]
13. 7683171 - [object Object]
14. 7642257 - Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
15. 7605273 - Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors